Explore

Trendline Trendline
Argenx Expands Immunology Portfolio with $2.2 Billion Acquisition of Forte Biosciences

Argenx Expands Immunology Portfolio with $2.2 Billion Acquisition of Forte Biosciences

Argenx Expands Immunology Portfolio with $2.2 Billion Acquisition of Forte Biosciences
Trendline Trendline
Argenx Acquires Forte Biosciences to Enhance Autoimmune Disease Portfolio

Argenx Acquires Forte Biosciences to Enhance Autoimmune Disease Portfolio

Argenx Acquires Forte Biosciences to Enhance Autoimmune Disease Portfolio
Trendline Trendline
Argenx Acquires Forte Biosciences for $2.2 Billion to Expand Immunology Pipeline

Argenx Acquires Forte Biosciences for $2.2 Billion to Expand Immunology Pipeline

Argenx Acquires Forte Biosciences for $2.2 Billion to Expand Immunology Pipeline
Trendline Trendline
Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment

Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment

Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment
Trendline Trendline
Oak Hill Bio and RACC Announce Merger to Advance Rare Disease Treatments

Oak Hill Bio and RACC Announce Merger to Advance Rare Disease Treatments

Oak Hill Bio and RACC Announce Merger to Advance Rare Disease Treatments
Trendline Trendline
Mapfre's $1.54 Billion Acquisition of Safety Insurance Group Involves Major Law Firms

Mapfre's $1.54 Billion Acquisition of Safety Insurance Group Involves Major Law Firms

Mapfre's $1.54 Billion Acquisition of Safety Insurance Group Involves Major Law Firms
Trendline Trendline
Paramount Delays Warner Bros. Merger Amid Antitrust Challenge from State Attorneys General

Paramount Delays Warner Bros. Merger Amid Antitrust Challenge from State Attorneys General

Paramount Delays Warner Bros. Merger Amid Antitrust Challenge from State Attorneys General
Trendline Trendline
United Airlines Explores Potential Merger with Delta Air Lines, Faces Antitrust Concerns

United Airlines Explores Potential Merger with Delta Air Lines, Faces Antitrust Concerns

United Airlines Explores Potential Merger with Delta Air Lines, Faces Antitrust Concerns
Trendline Trendline
Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition

Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition

Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition
Trendline Trendline
Expand Energy Acquires Twin Eagle Holdings for $1.25 Billion to Boost Gas Marketing

Expand Energy Acquires Twin Eagle Holdings for $1.25 Billion to Boost Gas Marketing

Expand Energy Acquires Twin Eagle Holdings for $1.25 Billion to Boost Gas Marketing
Trendline Trendline
Paramount Postpones Warner Bros. Merger Amid Antitrust Trial Concerns

Paramount Postpones Warner Bros. Merger Amid Antitrust Trial Concerns

Paramount Postpones Warner Bros. Merger Amid Antitrust Trial Concerns
Trendline Trendline
European Commission Approves Saudi Arabia's Acquisition of Electronic Arts Amid Concerns

European Commission Approves Saudi Arabia's Acquisition of Electronic Arts Amid Concerns

European Commission Approves Saudi Arabia's Acquisition of Electronic Arts Amid Concerns